🇺🇸 FDA
Patent

US 8580249

Cell therapy for the treatment of lysosomal storage disorders

granted A61KA61K35/48A61K38/44

Quick answer

US patent 8580249 (Cell therapy for the treatment of lysosomal storage disorders) held by Regents of the University of Minnesota expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/48, A61K38/44, A61K38/47, A61K48/00